Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Atomoxetine |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
Atomoxetine#Amber |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Dexamfetamine tablets |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Dexamfetamine tablets#Amber |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Guanfacine (Intuniv®) |
2nd line Atomoxetine, hospitals to manage/support patient. For the treatment of ADHD in children and adolescents 6-17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. |
|
|
|
Lisdexamfetamine |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Lisdexamfetamine#Red |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Methylphenidate M/R tablets |
Specialist initiation only, ESCA |
|
|
|
Methylphenidate tablets |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Methylphenidate tablets#Amber |
ESCAs and additional advice in relation to age of patient and CCG |
|
|
|
Modafinil tablets |
Specialist initiation only. For treatment of narcolepsy only. |
|
|
|
Solriamfetol (Sunosi®) |
